KCM
EIGR
Knoll Capital Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-585,966
| Closed | -$586K | – | 37 |
|
|
2022
Q3 | $586K | Sell |
585,966
-108,266
| -16% | -$108K | 0.34% | 18 |
|
|
2022
Q2 | $4.37M | Hold |
694,232
| – | – | 2.5% | 3 |
|
|
2022
Q1 | $5.76M | Hold |
694,232
| – | – | 3.62% | 3 |
|
|
2021
Q4 | $3.6M | Hold |
694,232
| – | – | 1.98% | 6 |
|
|
2021
Q3 | $4.64M | Hold |
694,232
| – | – | 2.31% | 7 |
|
|
2021
Q2 | $5.92M | Hold |
694,232
| – | – | 3.09% | 7 |
|
|
2021
Q1 | $6.14M | Hold |
694,232
| – | – | 4% | 7 |
|
|
2020
Q4 | $8.53M | Buy |
694,232
+98,994
| +17% | +$1.22M | 5.82% | 3 |
|
|
2020
Q3 | $4.85M | Buy |
595,238
+70,000
| +13% | +$570K | 3.97% | 5 |
|
|
2020
Q2 | $5.06M | Buy |
525,238
+50,000
| +11% | +$482K | 2.92% | 6 |
|
|
2020
Q1 | $3.23M | Buy |
475,238
+125,000
| +36% | +$850K | 3.04% | 7 |
|
|
2019
Q4 | $5.22M | Hold |
350,238
| – | – | 3.85% | 6 |
|
|
2019
Q3 | $3.59M | Hold |
350,238
| – | – | 3.29% | 8 |
|
|
2019
Q2 | $3.71M | Buy |
350,238
+275,000
| +366% | +$2.92M | 3.04% | 8 |
|
|
2019
Q1 | $1.05M | Hold |
75,238
| – | – | 0.8% | 14 |
|
|
2018
Q4 | $764K | Hold |
75,238
| – | – | 0.87% | 10 |
|
|
2018
Q3 | $910K | Hold |
75,238
| – | – | 0.77% | 13 |
|
|
2018
Q2 | $918K | Hold |
75,238
| – | – | 0.78% | 12 |
|
|
2018
Q1 | $741K | Buy |
+75,238
| New | +$741K | 0.76% | 11 |
|